{{cart_num}}
My CartCAS：69304-47-8
Molecular Formula：C11H13BrN2O5
Molecular Weight：333.14
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 69304-47-8 |
| Name | Brivudine |
| Molecular Formula | C11H13BrN2O5 |
| Molecular Weight | 333.14 |
| Solubility | Soluble in DMSO ≥5mg/mL(Need ultrasonic) |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 1806241-263-5 |
| MDL | MFCD00058585 |
| SMILES | OC[C@@H]1[C@H](C[C@H](N2C(NC(C(/C=C/Br)=C2)=O)=O)O1)O |
| Target Point | CMV |
| Passage | Anti-infection |
| Background | Brivudine is an uridine analogue and nucleoside analogue that incorporates viral DNA and blocks the action of DNA polymerase, thereby inhibiting viral replication. |
| Biological Activity | Brivudine是具有抗病毒活性的胸苷类似物,用于治疗早期急性带状疱疹。[1-2] |
| Data Literature Source | [1]. Rabasseda X，et al. Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing. Drugs Today (Barc). 2003 May;39(5):359-71. [2]. Keam SJ，et al. Brivudin (bromovinyl deoxyuridine). Drugs. 2004;64(18):2091-7; discussion 2098-9 |
| Unit | Bottle |
| Specification | 5mg 10mg 50mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
